Department of Gastrointestinal Surgery, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, Guangdong Institute of Gastroenterology, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Colorectal Dis. 2021 Sep;23(9):2301-2310. doi: 10.1111/codi.15691. Epub 2021 May 12.
The incidence of presacral tumours is low and pertinent data on the management and outcomes after surgery are sparse. The aim of this study was to identify the risk factors for recurrence in patients with presacral tumours undergoing surgery at our institution.
Patients undergoing resection of a presacral tumour between 2009 and 2019 were identified from a prospectively maintained database. Demographics, clinicopathological features, preoperative imaging, operative details, morbidity, mortality, recurrence and survival were investigated.
A total of 122 patients were identified. There were 95 women (77.9%) and the median age was 34 years. The most common presenting symptoms included pelvic pain (n = 60, 49.2%) and recurrent abscesses or fistulas (n = 40, 32.8%). The accuracy of preoperative magnetic resonance imaging (MRI) in distinguishing malignant from benign tumours was 93.9%. Six patients underwent three-dimensional computed tomography angiography (3D-CTA) and preoperative interventional embolization. Procedures were performed using transabdominal (n = 9), posterior (n = 99) and combined abdominal and posterior (n = 14) approaches. There were 21 (17.2%) malignant and 101 (82.8%) benign tumours. The local recurrence rate was 33.3% for malignant tumours and 9.9% for benign tumours. Multivariate analysis revealed that recurrence of malignant tumours was associated with R1 resection while recurrence of benign tumours was associated with secondary resections and intraoperative lesion rupture.
Presacral tumours continue to be a diagnostic and therapeutic challenge. A multidisciplinary team, informed by modern imaging modalities, is essential for the management of presacral tumours.
直肠前肿瘤的发病率较低,有关手术治疗和预后的数据也很少。本研究旨在确定在我院接受手术治疗的直肠前肿瘤患者复发的相关风险因素。
从一个前瞻性维护的数据库中确定了 2009 年至 2019 年期间接受直肠前肿瘤切除术的患者。调查了患者的人口统计学、临床病理学特征、术前影像学、手术细节、发病率、死亡率、复发和生存情况。
共确定了 122 名患者。其中女性 95 例(77.9%),中位年龄为 34 岁。最常见的症状包括盆腔疼痛(n=60,49.2%)和复发性脓肿或瘘管(n=40,32.8%)。术前磁共振成像(MRI)鉴别良恶性肿瘤的准确性为 93.9%。6 例患者进行了三维计算机断层血管造影(3D-CTA)和术前介入栓塞。手术采用经腹(n=9)、后入路(n=99)和联合经腹和后入路(n=14)进行。其中恶性肿瘤 21 例(17.2%),良性肿瘤 101 例(82.8%)。恶性肿瘤的局部复发率为 33.3%,良性肿瘤为 9.9%。多因素分析显示,恶性肿瘤的复发与 R1 切除有关,而良性肿瘤的复发与二次切除和术中肿瘤破裂有关。
直肠前肿瘤仍然是一个诊断和治疗的挑战。一个多学科团队,在现代影像学的指导下,对直肠前肿瘤的治疗至关重要。